Home » Health » Low blood sugar levels with JAK inhibitors | MedicalFacts.nl

Low blood sugar levels with JAK inhibitors | MedicalFacts.nl



The JAK inhibitors (janus kinase inhibitors) baricitinib and tofacitinib may have a glucose-lowering effect in patients with diabetes mellitus. As a result, patients sometimes have to adjust the diabetes medication.

A total of 32 reports of reduced glucose levels with tofacitinib and baricitinib were received in Europe, three of which were in the Netherlands. Patients were taking the medication for a rheumatic disease and also had diabetes. All reports showed a decreased or even too low glucose level in the blood after starting the JAK inhibitor. Sometimes the dosage of diabetes medication had to be reduced as a result. The dose of diabetes medication also had to be increased again after the JAK inhibitor was discontinued.

poster-pos0669

JAK inhibitors are used in rheumatoid arthritis and other chronic inflammatory diseases such as psoriatic arthritis, ulcerative colitis and atopic eczema. The research was presented during the online rheumatology congress EULAR. View the poster of the EULAR Congress here (in English)

Source: Lareb and EULAR

Previous articleWarning of possible Guillain-Barré syndrome after vaccination with Vaxzevria, vaccine from AstraZeneca

Next articleIncrease in number of corona infections in nursing homes is not surprising’

I have specialized in interactive news for healthcare providers, so that healthcare providers are informed every day of the news that may be relevant to them. Both lay news and news specific to healthcare providers and prescribers. Social Media, Womens Health, Patient advocacy, patient empowerment, personalized medicine & Care 2.0 are spearheads for me to pay extra attention to. I studied Physiotherapy and Health Care Business Administration. I have a lot of experience in various positions in the medical, pharmaceutical and healthcare industries. And have broad medical knowledge of most specialties in healthcare. I attend most of the leading medical conferences in Europe and America every year to keep my knowledge up-to-date and to keep up with the latest developments and innovations My posts on this blog do not reflect strategy, policy or direction of neither an employer nor are they activities of or for a client or employer.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.